3P  Biopharmaceuticals is a CMO (Contract Manufacturing Organization) with capability to develop and manufacture recombinant proteins for therapeutic uses, in adequate quantities and quality for preclinical and clinical trial phases I, II, III and commercial stages. It also offers development of products and processes necessary for cellular and gene therapy, and recombinant proteins for non-therapeutic uses.

3P Biopharmaceuticals, in collaboration with its technology partners, offers a COMPREHENSIVE SERVICE, assisting its clients from the initial research stage to the commercial phase in terms of every need arising including the development and manufacture of active ingredients (API), pharmaceutical development and essential regulatory aspects.